RhumbLine Advisers’s Nanobiotix NBTX Stock Holding History

RhumbLine Advisers’s Portfolio NBTX Stock Details NBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.6K	Sell	1,502 -779	-34%	-$29K	﹤0.01%	3660
2026 Q1	$70.4K	Sell	2,281 -61	-3%	-$1.61K	﹤0.01%	3519
2025 Q4	$54.1K	Buy	2,342 +2,309	+6,997%	+$50.4K	﹤0.01%	3621
2025 Q3	$623	Hold	33	–	–	﹤0.01%	4051
2025 Q2	$156	Hold	33	–	–	﹤0.01%	4100
2025 Q1	$116	Hold	33	–	–	﹤0.01%	4098
2024 Q4	$94	Hold	33	–	–	﹤0.01%	4135
2024 Q3	$189	Hold	33	–	–	﹤0.01%	4153
2024 Q2	$165	Hold	33	–	–	﹤0.01%	4328
2024 Q1	$205	Hold	33	–	–	﹤0.01%	4217
2023 Q4	$240	Hold	33	–	–	﹤0.01%	4230
2023 Q3	$288	Buy	+33	New	+$274	﹤0.01%	4257

Other funds holding NBTX

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SHIM

Stone House Investment Management Tunkhannock, Pennsylvania $752M AUM 20.1% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

RhumbLine Advisers's NBTX Position: Q2 2026 in Review

RhumbLine Advisers reduced its Nanobiotix (NBTX) stake by 34% in Q2 2026, selling an estimated $29K and leaving 1,502 shares worth $56.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3660.

RhumbLine Advisers first reported a position in NBTX in Q3 2023 and has held it in 12 quarters since. The position peaked at $70.4K in Q1 2026. 11 funds tracked by Wall St. Rank hold NBTX as of Q2 2026.

RhumbLine Advisers held 1,502 shares of Nanobiotix worth $56.6K as of Q2 2026.
RhumbLine Advisers sold 779 Nanobiotix shares in Q2 2026, an estimated $29K.
Nanobiotix made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3660 holding.
RhumbLine Advisers first reported a position in Nanobiotix in Q3 2023 and has held it in 12 quarters since.
RhumbLine Advisers's Nanobiotix position peaked at $70.4K in Q1 2026.
11 funds tracked by Wall St. Rank held Nanobiotix as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.